Insulet Management to Present at Wells Fargo Healthcare Conference
Event summary
- Insulet Corporation (NASDAQ: PODD) will present at the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026, at 2:15 p.m. ET.
- The presentation will be available via live webcast and replay on Insulet’s Investor Relations website.
- Insulet is a global leader in tubeless insulin pump technology, known for its Omnipod® brand products.
- The company’s Omnipod 5 Automated Insulin Delivery System integrates with continuous glucose monitors for automated insulin management.
The big picture
Insulet’s participation in the Wells Fargo Healthcare Conference underscores its position as a key player in the diabetes management technology space. The event provides a platform for the company to showcase its innovative Omnipod products and discuss its strategic direction amid increasing competition in the medical device sector. The focus on tubeless insulin delivery systems aligns with broader industry trends toward more user-friendly and automated diabetes care solutions.
What we're watching
- Product Innovation
- How Insulet’s Omnipod 5 system will compete in the automated insulin delivery market.
- Market Expansion
- Whether Insulet can sustain growth in non-insulin drug delivery applications.
- Investor Sentiment
- The impact of the conference presentation on investor confidence and stock performance.
Related topics